Gehrke T, Sers C, Morawietz L, Fernahl G, Neidel J, Frommelt L, Krenn V
ENDO-Klinik Hamburg, Germany.
Scand J Rheumatol. 2003;32(5):287-94. doi: 10.1080/03009740310003929.
The pathogenesis of periprosthetic bone loss in aseptic and septic prosthesis loosening is unclear. There is considerable evidence that macrophages and osteoclasts play a key role in focal bone erosion and osteolysis around the prosthesis. RANKL (receptor activator of nuclear factor kappaB ligand) was shown to be a potent osteoclastogenic factor, and to be involved in bone destruction of myeloma and rheumatoid arthritis patients. Osteoprotegerin (OPG) is the natural RANKL inhibitor and may prevent periprosthetic bone loss.
The presence and distribution of RANKL, its receptor RANK and OPG in the periprosthetic interface of septically (n = 5) and aseptically (n = 6) loosened prostheses was examined by immunohistochemistry and immunoblotting. Additionally, the immunophenotype of the inflammatory infiltrate was determined [CD3, CD68, Ki-67, tartrate-resistant acid posphatase (TRAP)].
Aseptic and septic cases revealed a different histopathologic pattern. However, in all cases RANKL and RANK could be demonstrated in macrophages and giant cells. In addition, RANKL detected by immunoblot analysis proved to have the same molecular weight as a recombinant RANKL used as a control (31 kD and approximately 48 kD). OPG was detected in aseptic loosening, where macrophages showed a strong staining, but multinucleated giant cells were only weakly stained. A weak OPG staining was also observed in septic loosening.
The pathogenesis of bone loss in septic loosening remains unclear, because the septic membrane bears few macrophages and giant cells, and half of them express OPG. In aseptic loosening, macrophages might not be stimulated by RANKL as a result of OPG expression. But multinucleated giant cells may be activated, as they hardly express OPG. They might be responsible for periprosthetic bone loss in aseptic loosening as a result of their RANKL and RANK expression.
无菌性和感染性假体松动中假体周围骨质流失的发病机制尚不清楚。有大量证据表明,巨噬细胞和破骨细胞在假体周围的局灶性骨侵蚀和骨溶解中起关键作用。核因子κB受体活化因子配体(RANKL)被证明是一种有效的破骨细胞生成因子,并参与骨髓瘤和类风湿性关节炎患者的骨破坏。骨保护素(OPG)是天然的RANKL抑制剂,可能预防假体周围骨质流失。
通过免疫组织化学和免疫印迹法检测感染性(n = 5)和无菌性(n = 6)松动假体周围界面中RANKL、其受体RANK和OPG的存在及分布。此外,确定炎症浸润的免疫表型[CD3、CD68、Ki-67、抗酒石酸酸性磷酸酶(TRAP)]。
无菌性和感染性病例呈现不同的组织病理学模式。然而,在所有病例中,巨噬细胞和巨细胞中均可检测到RANKL和RANK。此外,免疫印迹分析检测到的RANKL被证明与用作对照的重组RANKL具有相同的分子量(31 kD和约48 kD)。在无菌性松动中检测到OPG,其中巨噬细胞显示强染色,但多核巨细胞仅显示弱染色。在感染性松动中也观察到OPG弱染色。
感染性松动中骨质流失的发病机制仍不清楚,因为感染性包膜中巨噬细胞和巨细胞较少,且其中一半表达OPG。在无菌性松动中,由于OPG的表达,巨噬细胞可能不会被RANKL刺激。但多核巨细胞可能被激活,因为它们几乎不表达OPG。由于它们表达RANKL和RANK,它们可能是无菌性松动中假体周围骨质流失的原因。